Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
CURE, 2001 | clopidogrel + aspirin | aspirin | | | Suggesting | |
CURE (PCI sub study), 2001 | clopidogrel | placebo | | Exploratory | - | |
COMMIT, 2005 | clopidogrel | placebo | | | Suggesting | NCT00222573 |
CLARITY-TIMI 28, 2005 | clopidogrel | placebo | | | - | |
CURRENT OASIS 7 (clopidogrel), 2010 | clopidogrel high-dose regimen | clopidogrel standard-dose | | Low risk of bias | Negative | NCT00335452 |
|
COMMIT, 2005 | clopidogrel | placebo | | | Suggesting | NCT00222573 |
CLARITY-TIMI 28, 2005 | clopidogrel | placebo | | | - | |
|
ACTIVE W, 2006 | aspirin + clopidogrel | anticoagulant | | Risk of bias | Suggesting | NCT00243178 |
ACTIVE A, 2009 | aspirin + clopidogrel | aspirin | | Low risk of bias | Suggesting | NCT00249873 |
|
CASCADE, 2009 | clopidogrel+aspirin | aspirin | | Exploratory | - | NCT00228423 |
|
ASCET | clopidogrel | aspirin | | Risk of bias | Negative | NCT00222261 |
CAPRIE (PAD subgroup), 1996 | clopidogrel | aspirin | | | Suggesting | |
CAPRIE, 1996 | clopidogrel | aspirin | secondary prevention | Low risk of bias | Suggesting | |
CHARISMA, 2006 | clopidogrel | placebo (on top aspirin) | secondary prevention | Low risk of bias | Suggesting | NCT00050817 |
|
ASCET | clopidogrel | aspirin | | Risk of bias | Negative | NCT00222261 |
CAPRIE, 1996 | clopidogrel | aspirin | | | - | |
|
WATCH (clopidogrel vs aspirin) ongoing | clopidogrel | aspirin | | | - | |
|
CLASSICS, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
Müller, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
TOPPS, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
Piamsomboon, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
REAL-LATE, ZEST-LATE, 2010 | clopidogrel+aspirin | aspirin | | | Negative | NCT00484926 |
GRAVITAS, 2011 | high-dose clopidogrel | normal-dose clopidogrel | | Risk of bias | Negative | NCT00645918 |
|
CAPRIE (PAD subgroup), 1996 | clopidogrel | aspirin | | | Suggesting | |
AFFIRM ongoing | clopidogrel | | | | - | |
|
CAPRIE, 1996 | clopidogrel | aspirin | | | - | |
|
ASCET | clopidogrel | aspirin | | Risk of bias | Negative | NCT00222261 |
|
Müller, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
CLASSICS, 2000 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
Piamsomboon, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
TOPPS, 2001 | clopidogrel + aspirin | ticlopidine + aspirin | | | Negative | |
REAL-LATE, ZEST-LATE, 2010 | clopidogrel+aspirin | aspirin | | | Negative | NCT00484926 |
GRAVITAS, 2011 | high-dose clopidogrel | normal-dose clopidogrel | | Risk of bias | Negative | NCT00645918 |